Geoff dow, phd, infectious disease product development expert, to discuss babesiosis at healing lyme summit, april 15-21

Washington, april 10, 2025 (globe newswire) -- geoff dow, infectious disease product development expert and chief executive officer of 60 degrees pharmaceuticals, inc. (nasdaq: sxtp; sxtpw) (“60 degrees” or the “company”), will participate in a scientific discussion on the management and treatment of babesiosis during the april 15–21 healing lyme summit. babesiosis is a rapidly emerging tick-borne disease often found as a coinfection with lyme disease.
DOW Ratings Summary
DOW Quant Ranking